ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2023 and some content may be unavailable. To unlock all content for 2023, please visit the archives.

Abstract: FR-PO034

The Acceptability and Usability of My Kidneys & Me, a Digital Self-Management Health Intervention for CKD

Session Information

Category: Augmented Intelligence, Digital Health, and Data Science

  • 300 Augmented Intelligence, Digital Health, and Data Science


  • Lightfoot, Courtney Jane, University of Leicester, Leicester, United Kingdom
  • Wilkinson, Thomas James, University of Leicester, Leicester, United Kingdom
  • Graham-Brown, Matthew, University of Leicester, Leicester, United Kingdom
  • Smith, Alice C., University of Leicester, Leicester, United Kingdom

The use of digital health interventions (DHIs) to provide education and support has rapidly increased, especially in the post-COVID era, due to potential cost-effectiveness and ease of equitable delivery. We co-developed My Kidneys & Me (MK&M), an educational self-management DHI for CKD. Here we report the usage metrics of MK&M during a 20-week evaluation.


As part of a randomized trial, participants at 26 UK sites were given access to MK&M for 20-weeks. MK&M provided online education sessions (underpinned by behaviour change theory), and digital applications to track goals, symptoms, physical activity, and clinical measures. Access to and usage data of MK&M were collected, alongside perceived usefulness (scored from 0 (not useful at all) to 10 (very useful)). Frequency analysis identified the frequency and length of time spent on MK&M sessions.


281 patients received MK&M (age 60.8±12.8 years, 58% male, eGFR 38.9±18.5 ml/min/1.73m2). 205 (73%) used MK&M at least once. The median number of logins per person was 10.0 (IQR 4.0-28.0). The median time per login was 12 mins (IQR 7-25 mins). ‘The kidneys’ was the most accessed session (n=152 participants). Table 1 displays top three sessions by total number times accessed and total duration spent on session. All sessions scored ≥7/10, with ‘Kidney disease and general health’ considered the most useful session (8.7/10). Goal setting was considered the most useful tracker (8.5/10) and symptoms the least (6.7/10).


MK&M was well received and utilised by participants. Our findings show that people with CKD are capable and willing to use DHIs for kidney health. Identification of real-life usage and usability issues will help refine MK&M, improving the content and delivery before clinical implementation.

Top three sessions by the total number of times session accessed and total duration of time spent on the session per participant
Total number of times session accessed per participant
 Session titleMedian (n)IQR
1Managing my symptoms1515-17
2How to move more and be active1313-18
3Treatment options available1313-15
Total duration of time spent on session per participant
 Session titleMedian (mins)IQR
1Kidney disease and general health116-22
2Kidney disease116-17
3Treatment options available95-16

NB. IQR: interquartile range